Osteoporosis Treatment: Medications, Lifestyle & Emerging Therapies

Comprehensive Osteoporosis Management

1. Pharmacotherapy (Fracture Risk–Guided)

ClassAgentsMechanismIndication
BisphosphonatesAlendronate, risedronate, ibandronate, zoledronic acidAntiresorptive (inhibit osteoclast)First-line; oral/IV
DenosumabProlia (60 mg SC q6mo)Anti-RANKL (antiresorptive)High risk, renal impairment, BP intolerant
AnabolicsTeriparatide, abaloparatide (daily SC × 2 yr max)Stimulate osteoblast → new boneVery high risk, fractures on antiresorptives
RomosozumabEvenity (210 mg SC qmo × 1 yr)Anti-sclerostin (anabolic + antiresorptive)Very high risk; CV caution
SERMRaloxifeneEstrogen agonist on bonePostmenopausal; also ↓breast Ca risk
HRTEstrogen ± progestinAntiresorptiveYoung postmenopausal with symptoms

2. Lifestyle Foundation

  • Calcium 1200 mg/day (diet + supplement)
  • Vitamin D 2000–4000 IU/day (target 30–50 ng/mL)
  • Weight-bearing + resistance exercise 3–4×/wk
  • Fall prevention: balance training, home safety, vision check
  • Smoking cessation, alcohol ≤2 drinks/day

3. Monitoring

  • DEXA q1–2 yr (spine/hip)
  • Bone turnover markers (CTX, P1NP) for adherence/response
  • Drug holiday assessment after 3–5 yr (bisphosphonates)

Treatment individualized by FRAX score, fracture history, comorbidities, patient preference.

Osteoporosis - Related Articles